Total number of protein in "GO:0060170" GO term: 59
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADCY3-213 | ADCY3 | O60266 | Adenylate cyclase type 3 | chr2 | GO:0060170 | Not Cancer Driver | No | 105 | 0.0917832167832167 | 186 | 16 | 0.0139860139860139 | 0 |
| ARL13A-203 | ARL13A | Q5H913 | ADP-ribosylation factor-like protein 13A | chrX | GO:0060170 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| ARL13B-203 | ARL13B | Q3SXY8 | ADP-ribosylation factor-like protein 13B | chr3 | GO:0060170 | Not Cancer Driver | No | 48 | 0.1121495327102803 | 251 | 34 | 0.0794392523364486 | 3 |
| BBIP1-207 | BBIP1 | A8MTZ0 | BBSome-interacting protein 1 | chr10 | GO:0060170 | Not Cancer Driver | No | 0 | 0.0 | 63 | 0 | 0.0 | 0 |
| BBS1-201 | BBS1 | Q8NFJ9 | Bardet-Biedl syndrome 1 protein | chr11 | GO:0060170 | Not Cancer Driver | No | 52 | 0.087689713322091 | 100 | 9 | 0.0151770657672849 | 11 |
| BBS2-201 | BBS2 | Q9BXC9 | Bardet-Biedl syndrome 2 protein | chr16 | GO:0060170 | Not Cancer Driver | No | 60 | 0.0832177531206657 | 76 | 8 | 0.0110957004160887 | 20 |
| BBS4-201 | BBS4 | Q96RK4 | Bardet-Biedl syndrome 4 protein | chr15 | GO:0060170 | Not Cancer Driver | No | 44 | 0.0847784200385356 | 111 | 14 | 0.0269749518304431 | 9 |
| BBS5-201 | BBS5 | Q8N3I7 | Bardet-Biedl syndrome 5 protein | chr2 | GO:0060170 | Not Cancer Driver | No | 24 | 0.0703812316715542 | 20 | 0 | 0.0 | 2 |
| BBS7-201 | BBS7 | Q8IWZ6 | Bardet-Biedl syndrome 7 protein | chr4 | GO:0060170 | Not Cancer Driver | No | 69 | 0.0965034965034965 | 56 | 4 | 0.0055944055944055 | 4 |
| BBS9-201 | BBS9 | Q3SYG4 | Protein PTHB1 | chr7 | GO:0060170 | Not Cancer Driver | No | 128 | 0.1443066516347237 | 103 | 16 | 0.0180383314543404 | 1 |
| CASK-203 | CASK | O14936 | Peripheral plasma membrane protein CASK | chrX | GO:0060170 | Not Cancer Driver | No | 80 | 0.0863930885529157 | 285 | 27 | 0.029157667386609 | 4 |
| CLTB-201 | CLTB | P09497 | Clathrin light chain B | chr5 | GO:0060170 | Not Cancer Driver | No | 19 | 0.0829694323144104 | 193 | 15 | 0.0655021834061135 | 0 |
| CNGA2-201 | CNGA2 | Q16280 | Cyclic nucleotide-gated olfactory channel | chrX | GO:0060170 | Not Cancer Driver | No | 125 | 0.1882530120481927 | 161 | 31 | 0.0466867469879518 | 0 |
| CNGA4-201 | CNGA4 | Q8IV77 | Cyclic nucleotide-gated cation channel alpha-4 | chr11 | GO:0060170 | Not Cancer Driver | No | 97 | 0.168695652173913 | 80 | 10 | 0.017391304347826 | 0 |
| CNGB1-201 | CNGB1 | Q14028 | Cyclic nucleotide-gated cation channel beta-1 | chr16 | GO:0060170 | Not Cancer Driver | No | 156 | 0.1247002398081534 | 797 | 93 | 0.0743405275779376 | 1 |
| CYS1-201 | CYS1 | Q717R9 | Cystin-1 | chr2 | GO:0060170 | Not Cancer Driver | No | 4 | 0.0253164556962025 | 158 | 4 | 0.0253164556962025 | 0 |
| DRD1-201 | DRD1 | P21728 | D(1A) dopamine receptor | chr5 | GO:0060170 | Not Cancer Driver | No | 49 | 0.1098654708520179 | 30 | 3 | 0.0067264573991031 | 0 |
| DRD2-202 | DRD2 | P14416 | D(2) dopamine receptor | chr11 | GO:0060170 | Not Cancer Driver | No | 91 | 0.2054176072234763 | 124 | 31 | 0.0699774266365688 | 0 |
| DRD5-201 | DRD5 | P21918 | D(1B) dopamine receptor | chr4 | GO:0060170 | Not Cancer Driver | No | 122 | 0.2557651991614256 | 29 | 16 | 0.0335429769392033 | 0 |
| EFCAB7-201 | EFCAB7 | A8K855 | EF-hand calcium-binding domain-containing protein 7 | chr1 | GO:0060170 | Not Cancer Driver | No | 59 | 0.0937996820349761 | 97 | 12 | 0.0190779014308426 | 0 |
| ENST00000419755 | BBS1 | Q8NFJ9 | Bardet-Biedl syndrome 1 protein | chr11 | GO:0060170 | Not Cancer Driver | No | 52 | 0.0825396825396825 | 132 | 7 | 0.0111111111111111 | 11 |
| EVC-201 | EVC | P57679 | EvC complex member EVC | chr4 | GO:0060170 | Not Cancer Driver | No | 103 | 0.1038306451612903 | 376 | 40 | 0.0403225806451612 | 4 |
| EVC2-202 | EVC2 | Q86UK5 | Limbin | chr4 | GO:0060170 | Not Cancer Driver | No | 184 | 0.1406727828746177 | 340 | 56 | 0.0428134556574923 | 2 |
| FFAR4-201 | FFAR4 | Q5NUL3 | Free fatty acid receptor 4 | chr10 | GO:0060170 | Not Cancer Driver | No | 36 | 0.0997229916897507 | 0 | 0 | 0.0 | 0 |
| GPI-201 | GPI | P06744 | Glucose-6-phosphate isomerase | chr19 | GO:0060170 | Not Cancer Driver | No | 56 | 0.1003584229390681 | 73 | 10 | 0.017921146953405 | 23 |
| GPR157-201 | GPR157 | Q5UAW9 | G-protein coupled receptor 157 | chr1 | GO:0060170 | Not Cancer Driver | No | 26 | 0.0776119402985074 | 38 | 5 | 0.0149253731343283 | 0 |
| GPR161-211 | GPR161 | Q8N6U8 | G-protein coupled receptor 161 | chr1 | GO:0060170 | Not Cancer Driver | No | 60 | 0.1134215500945179 | 108 | 14 | 0.0264650283553875 | 0 |
| GPR37L1-201 | GPR37L1 | O60883 | G-protein coupled receptor 37-like 1 | chr1 | GO:0060170 | Not Cancer Driver | No | 43 | 0.0893970893970894 | 82 | 7 | 0.0145530145530145 | 0 |
| GPR88-201 | GPR88 | Q9GZN0 | Probable G-protein coupled receptor 88 | chr1 | GO:0060170 | Not Cancer Driver | No | 12 | 0.03125 | 30 | 0 | 0.0 | 0 |
| HHIP-201 | HHIP | Q96QV1 | Hedgehog-interacting protein | chr4 | GO:0060170 | Not Cancer Driver | No | 103 | 0.1471428571428571 | 75 | 23 | 0.0328571428571428 | 0 |
| IQCE-203 | IQCE | Q6IPM2 | IQ domain-containing protein E | chr7 | GO:0060170 | Not Cancer Driver | No | 64 | 0.0920863309352518 | 637 | 58 | 0.0834532374100719 | 0 |
| MOSMO-202 | MOSMO | Q8NHV5 | Modulator of smoothened protein | chr16 | GO:0060170 | Not Cancer Driver | No | 1 | 0.0059880239520958 | 0 | 0 | 0.0 | 0 |
| MXRA8-201 | MXRA8 | Q9BRK3 | Matrix remodeling-associated protein 8 | chr1 | GO:0060170 | Not Cancer Driver | No | 35 | 0.0791855203619909 | 92 | 7 | 0.0158371040723981 | 0 |
| PKD1-201 | PKD1 | P98161 | Polycystin-1 | chr16 | GO:0060170 | Not Cancer Driver | No | 299 | 0.0694864048338368 | 695 | 50 | 0.0116198001394376 | 91 |
| PKD1L1-201 | PKD1L1 | Q8TDX9 | Polycystin-1-like protein 1 | chr7 | GO:0060170 | Not Cancer Driver | No | 385 | 0.1351351351351351 | 527 | 79 | 0.0277290277290277 | 1 |
| PKD2-201 | PKD2 | Q13563 | Polycystin-2 | chr4 | GO:0060170 | Not Cancer Driver | No | 88 | 0.0909090909090909 | 376 | 30 | 0.03099173553719 | 9 |
| PKD2L1-201 | PKD2L1 | Q9P0L9 | Polycystin-2-like protein 1 | chr10 | GO:0060170 | Not Cancer Driver | No | 98 | 0.1217391304347826 | 182 | 22 | 0.0273291925465838 | 0 |
| PROM2-201 | PROM2 | Q8N271 | Prominin-2 | chr2 | GO:0060170 | Not Cancer Driver | No | 89 | 0.1067146282973621 | 34 | 5 | 0.0059952038369304 | 0 |
| PTCH1-201 | PTCH1 | Q13635 | Protein patched homolog 1 | chr9 | GO:0060170 | Census, Compendium | Yes | 156 | 0.1078092605390463 | 383 | 39 | 0.0269523151347615 | 17 |
| RAB8A-201 | RAB8A | P61006 | Ras-related protein Rab-8A | chr19 | GO:0060170 | Not Cancer Driver | No | 30 | 0.144927536231884 | 26 | 3 | 0.0144927536231884 | 0 |
| RHO-201 | RHO | P08100 | Rhodopsin | chr3 | GO:0060170 | Not Cancer Driver | No | 50 | 0.1436781609195402 | 18 | 2 | 0.0057471264367816 | 50 |
| SCNN1A-201 | SCNN1A | P37088 | Amiloride-sensitive sodium channel subunit alpha | chr12 | GO:0060170 | Not Cancer Driver | No | 66 | 0.0986547085201793 | 148 | 17 | 0.0254110612855007 | 5 |
| SEPTIN2-203 | SEPTIN2 | Q15019 | Septin-2 | chr2 | GO:0060170 | Not Cancer Driver | No | 34 | 0.0941828254847645 | 101 | 4 | 0.0110803324099723 | 0 |
| SHANK2-214 | SHANK2 | Q9UPX8 | SH3 and multiple ankyrin repeat domains protein 2 | chr11 | GO:0060170 | Not Cancer Driver | No | 239 | 0.1292590589507842 | 1385 | 210 | 0.1135749053542455 | 0 |
| SHANK3-201 | SHANK3 | Q9BYB0 | SH3 and multiple ankyrin repeat domains protein 3 | chr22 | GO:0060170 | Not Cancer Driver | No | 98 | 0.0609831985065339 | 1257 | 68 | 0.0423148724331051 | 3 |
| SMO-201 | SMO | Q99835 | Protein smoothened | chr7 | GO:0060170 | Census, Compendium | Yes | 88 | 0.1118170266836086 | 242 | 20 | 0.025412960609911 | 1 |
| SSTR3-201 | SSTR3 | P32745 | Somatostatin receptor type 3 | chr22 | GO:0060170 | Not Cancer Driver | No | 76 | 0.1818181818181818 | 112 | 20 | 0.0478468899521531 | 0 |
| TAS2R4-201 | TAS2R4 | Q9NYW5 | Taste receptor type 2 member 4 | chr7 | GO:0060170 | Not Cancer Driver | No | 23 | 0.0769230769230769 | 0 | 0 | 0.0 | 0 |
| TAS2R43-201 | TAS2R43 | P59537 | Taste receptor type 2 member 43 | chr12 | GO:0060170 | Not Cancer Driver | No | 18 | 0.058252427184466 | 0 | 0 | 0.0 | 0 |
| TAS2R46-201 | TAS2R46 | P59540 | Taste receptor type 2 member 46 | chr12 | GO:0060170 | Not Cancer Driver | No | 28 | 0.0906148867313915 | 0 | 0 | 0.0 | 0 |
| TCTN2-201 | TCTN2 | Q96GX1 | Tectonic-2 | chr12 | GO:0060170 | Not Cancer Driver | No | 62 | 0.0889526542324246 | 23 | 2 | 0.0028694404591104 | 0 |
| TCTN3-203 | TCTN3 | Q6NUS6 | Tectonic-3 | chr10 | GO:0060170 | Not Cancer Driver | No | 32 | 0.0527182866556836 | 71 | 5 | 0.0082372322899505 | 1 |
| TMEM17-201 | TMEM17 | Q86X19 | Transmembrane protein 17 | chr2 | GO:0060170 | Not Cancer Driver | No | 15 | 0.0757575757575757 | 14 | 1 | 0.005050505050505 | 0 |
| TMEM231-201 | TMEM231 | Q9H6L2 | Transmembrane protein 231 | chr16 | GO:0060170 | Not Cancer Driver | No | 11 | 0.0348101265822784 | 16 | 0 | 0.0 | 2 |
| TMEM67-205 | TMEM67 | Q5HYA8 | Meckelin | chr8 | GO:0060170 | Not Cancer Driver | No | 85 | 0.0854271356783919 | 11 | 0 | 0.0 | 45 |
| TSPEAR-201 | TSPEAR | Q8WU66 | Thrombospondin-type laminin G domain and EAR repeat-containing protein | chr21 | GO:0060170 | Not Cancer Driver | No | 113 | 0.1689088191330343 | 7 | 1 | 0.0014947683109118 | 0 |
| TTC8-201 | TTC8 | Q8TAM2 | Tetratricopeptide repeat protein 8 | chr14 | GO:0060170 | Not Cancer Driver | No | 54 | 0.1016949152542373 | 78 | 11 | 0.0207156308851224 | 0 |
| TXNDC15-201 | TXNDC15 | Q96J42 | Thioredoxin domain-containing protein 15 | chr5 | GO:0060170 | Not Cancer Driver | No | 21 | 0.0583333333333333 | 137 | 10 | 0.0277777777777777 | 0 |
| UMOD-202 | UMOD | P07911 | Uromodulin | chr16 | GO:0060170 | Not Cancer Driver | No | 102 | 0.159375 | 12 | 0 | 0.0 | 33 |